Start Your Business Healthcare Consumable and Disposable Manufacturing

A high caliber Investment Professional with an experience amounting over 30 years, majorly across various facets of Investment.

HealthCare Consumable and Disposable

Definition of ‘consumable’

A medical consumable is a medical product, or product used for a therapeutic purpose that:

• is not a pharmaceutical
• is not re-usable
• a client is assessed as needing
• is required as a result of a client’s covered personal injury, to assist in restoring the client’s health, independence, and participation to the maximum extent practicable
• is cost effective, and
• has evidence to justify its use.

What is covered by the Medical Consumables?

Examples of consumable items needed by clients on an ongoing basis:

• wound care products
• respiratory products
• nutritional products
• gloves and protective items
• continence consumables
• ostomy consumables
• skin care products
• fluid and irrigation.

Our Strategy -- 3 X 3 Way of Diversified Strategy

¡ Productions

¡ Partners

¡ Agencies

Productions

¡ Adhesive Tapes and Medical Plastic Product Line

¡ Disposable Syringe and Similar Products with Same Product Line

¡ Inject Molding Product Line

Partners

¡ Partners will be our key strength.

¡ Technology

¡ Product

Scroll to Continue

The Civilized, Chapter 28 - English Translation of Les Civilisés

Interpreting the Meaning of Fire in Dreams

Evil Lurks in a Socialist Dress.

¡ White Label

¡ We would like to have three Partners

Agencies

¡ Disposable Item – Agencies from West to Represent them in MENA

¡ Consumable Item – Agencies from Global Names

¡ Medical Equipment – Agencies for Global Names to Represent Them in Kuwait

Healthcare Consumable and Disposable Project

Change is the new normal for the global health care sector. As providers, payers, governments, and other stakeholders strive to deliver effective, efficient, and equitable care, they do so in an ecosystem that is undergoing a dramatic and fundamental shift in business, clinical, and operating models.

This shift is being fueled by aging and growing populations; the proliferation of chronic diseases; heightened focus on care quality and value; evolving financial and quality regulations; informed and empowered consumers; and innovative treatments and technologies — all of which are leading to rising costs and an increase in spending levels for care provision, infrastructure improvements, and technology innovations.

Spending growth is anticipated to accelerate in 2016, topping four percent, and rise to over six percent a year in 2017 and 2018.

Growth in several markets — mostly in Asia and the Middle East — will be particularly rapid as public and private health care systems develop in some countries; in addition, the trend towards universal health care is likely to be a growth driver in numerous markets.4 However, the pressure to reduce costs, increase efficiency, and demonstrate value will continue to intensify. As a result of these contradictory trends, the EIU projects that global health care spending will increase by an average of 4.3 percent during 2015-2019, more slowly than it did before the 2009 recession. Average spending as a percentage of GDP is expected to decline from a forecasted 10.3 percent in 2015 to 10.1 percent in 2019.

Chronic and communicable diseases

The proliferation of chronic diseases — in part, a consequence of increased life expectancy — is having serious repercussions in both developed and emerging countries. Obesity, cardiovascular diseases, hypertension, and dementia are becoming persistent, widespread health problems and appear to be challenging public health systems to meet increasing demand for drugs and treatments.

The current number of people with diabetes globally is 387 million and that number is expected to increase to 592 million by 2035, according to the International Diabetes Federation. China and India have the largest number of diabetes sufferers in the world, at more than 96 million and 66 million, respectively.14

Global spending on health is expected to increase to $18.28 trillion worldwide by 2040 but many countries will miss important health benchmarks

Value-based care continues to transform industry, driving need for targeted therapies

Despite global political uncertainties and a sluggish economic outlook for 2017, the global healthcare industry is set for an invigorating year, according to a new analysis from Frost & Sullivan. This outlook is due to a partial realization of major healthcare policies and initiatives, technology advancements and value-based care driving the adoption and need for consumer-centric targeted therapies. Future drugs and medical devices will be more targeted to meet the unique needs of emerging markets (e.g. China, India, Brazil) which demonstrate high growth opportunities compared developed markets (e.g., the United States and Western Europe. Growing at a CAGR of 4.8 percent, the industry is likely to reach revenue of $1,731.8 billion.

Current predictions and trends from the analysis encouraging transformation include:

• Growth in remote patient monitoring (RPM) will start to accelerate beyond previous projections based on a convergence of regulatory, technology and ergonomic factors;

• A selective churn in the mobile health app space will differentiate the small number of vetted apps that will emerge as the best choice for serious health users;

• Life sciences and device industries will experience an increase in collaboration as well as merger and acquisition activities as they design products to prevent the onset of chronic and degenerative diseases;

• Artificial intelligence (AI) will play an important role in helping radiologists better interpret scans, reduce scan times, improve workflow efficiency and improve quality. AI will also make medical implants smarter as a way to intelligently regulate specific health conditions;

• Alternate payment models will drive the demand for next-generation revenue cycle management solutions. The adoption of alternative payment models will drive the usage of robust and agile analytics software that automates reporting and visualization of patient-specific information;

• Immunotherapy will become part of the toolbox for treatment of various types of cancers. Immuno-oncology will remain hot as leading pharmaceutical companies race to market the first chimeric antigen receptor T-cell (CAR-T) therapy in 2017; and

• Decreasing cost of next-generation sequencing tests to below the $1,000 mark will shift the application focus from research to clinical use cases.

• Future health spending is expected to increase at a much higher level of growth than in the past. By 2020, healthcare spending is projected to triple in real dollars, consuming 21% of GDP in the U.S. and 16% of GDP in other OECD countries.

• Transparency in quality and pricing was identified by more than 80% of HealthCast 2020 survey respondents as a contributor to sustainability.

• Preventive care and disease management programs have untapped potential to enhance health status and reduce costs, but require support and integration across the industry for their benefits to be realized. The most effective means of demand management, according to the HealthCast 2020 survey, are wellness, immunization and disease management programs.

• Industry leaders expect tremendous growth in consumer-oriented programs. Only 35% of respondents in the HealthCast 2020 survey said hospital systems are prepared to meet the demands of empowered consumers. But a large majority (85%) of organizations surveyed has initiated pay-for-performance initiatives, above the 70% who had started such programs in 2002.

• Information technology (IT) is an important enabler in resolving healthcare issues when there is system-wide and organizational commitment and investment. The vast majority of HealthCast 2020 survey respondents viewed IT as important or very important to integrate care (73%) and improve information sharing (78%). But IT is not a solution in and of itself. A smaller percentage saw IT as important or very important for improving patient safety (54%) or restoring patient trust (35%).

Healthcare Project Brief

• Project Report Healthcare Disposable and Consumable
  Covid19 has changed everything. The Supply Chain, and particularly localization of Basic Necessities will be focus for future. Health care will remain in focu…
• Disposable Syringe Production Process
  Disposable Syringe is One of Consumable used every day in millions. This is great business opportunity. Covid has made it more Important to Produce is Locally.…
• Care and cure Medical Laboratory
  Kuwait Healthcare Market has robust and growing fast. Laboratories specially working on unique ideas and solution has huge potential. Health Care Laboratory Un…
• Health Care Real Estate Fund -Islamic
  This is brief document about Fully Shariah Compliant Health Care Real Estate Fund. The ageing population is West has created huge opportunity for Senior Living…
• Saudi Healthcare City
  Healthcare Market is growing fast. The Changing lifestyle needs new solution. This is Healthcare City Proposal. This is integrated development which has long t…

Healthcare Budget

Manpower Requirement

Product Lineup

Best Prospects/Services

• Medical-dental-lab equipment

• General hospital supplies

• Pharmaceutical products and specialized systems and applications

• Laser-treatment, nanotechnology and molecular medicine

• Laboratory testing, testing equipment, and disposable tests

• Surgical instruments, diagnostic or laboratory equipment in the fields of orthopedics, trauma care, ophthalmology, cardiology, oncology, radiology or radiotherapy, and healthcare information

What is covered by the Medical Consumables?

Examples of consumable items needed by clients on an ongoing basis:

• wound care products
• respiratory products
• nutritional products
• gloves and protective items
• continence consumables
• ostomy consumables
• skin care products
• fluid and irrigation.

Our Strategy -- 3 X 3 Way of Diversified Strategy

¡ Productions

¡ Partners

¡ Agencies

Productions

¡ Adhesive Tapes and Medical Plastic Product Line

¡ Disposable Syringe and Similar Products with Same Product Line

¡ Inject Molding Product Line

Partners

¡ Partners will be our key strength.

¡ Technology

¡ Product

¡ White Label

¡ We would like to have three Partners

Agencies

¡ Disposable Item – Agencies from West to Represent them in MENA

¡ Consumable Item – Agencies from Global Names

¡ Medical Equipment – Agencies for Global Names to Represent Them in Kuwait

Our Product

For many single-use medical tubing applications, such as intravenous (IV) lines, transparent polymers are required for clinicians to assess fluid or gas flow through the tube. These tubes require polymers that are resistant to a wide range of cleaning agents and sterilization methods, and must be readily bondable to injection molded fitting and connectors. Common applications for such tubing include:Medical Tubing

Intravenous (IV) tubing

Umbilical artery catheters

Infusion tubing

Nasogastric tubes

Peritoneal dialysis tubing

Hemodialysis tubing

Polyvinyl chloride (PVC) offers an economical choice for many single-use, transparent tubing applications and is available in flexible and rigid grades.

Medical Grade Adhesive Tape - Skin Contact

Medical Grade Adhesive Tapes are FDA compliant for direct skin contact and designed for disposable, skin friendly applications. Medical and personal care applications include wound care, device attachment, wearable devices, medical sensors, ostomy & incontinence devices, diagnostics, surgical drapes, cosmetic accessories and adhesive bras.

Medical grade acrylate and silicone adhesives are typically breathable, anti-microbial, sterilizable, hypoallergenic, hydrophobic or hydrophilic. Hydrocolloid adhesives provide a range of good adhesion, fluid absorption and extended wear. Hydrophilic and hydrophobic tapes and films are moisture vapor permeable and help channel the direction of fluids. Electrically conductive adhesives, often used in ECG electrodes provide adhesion, yet can be cleanly removed. The liners are typically compatible when exposed to Gamma and Ethylene Oxide (EtO) Sterilization processes.

• Medical Adhesive Transfer Tape - Hi-Tack Adhesive
• Single Coated Polyester Medical Tape
• Double Coated Polyethylene Medical Tape - Transparent
• Medical Adhesive Transfer Tape - Polyester Fiber Filled
• Single Coated Polyethylene Medical Tape
• Single Coated Medical Plastic Tape - EVA Embossed Non-Perforated
• Single Coated Medical Plastic Tape - EVA Blend & Perforated
• Medical Nonwoven Rayon Tape
• Medical Woven Rayon Acetate Tape
• Polyurethane Film on White Carrier - Medical/Translucent
• Double Coated Polyethylene Medical Tape - Transparent
• Medical Nonwoven Elastic Tape
• Medical Nonwoven Spunlace Tape
• Avery .......................................................................................................................
• Transfer Tape
• Mactac......................................................................................................................
• Single Coated Polyester Medical Tape
• Medical Nonwoven Spunlace Polyester Tape
• Medical Woven Acetate Tape
• Single Coated Medical Nonwoven Polyester Spunlace Tape
• Single Coated Medical Nonwoven Polyethylene Tape
• Differential Double Coated Polyester Medical Tape - Permanent Rubber/Removable Acrylic
• Single Coated Polyester Medical Tape
• Polyurethane Film - Medical/Elastic
• Polyken Double Coated Polyester Medical Tape
• Polyken Flexible Film Medical Tape
• Polyken Medical Nonwoven Spunlace Polyester Tape
• BANDAGE ADHESIVE..................................................................... BANDAGE CASTING
• BANDAGE COHESIVE............................................................ BANDAGE COMPRESSION
• BANDAGE CONFORMING.................................................................. BANDAGE CREPE
• BANDAGE TAPES......................................................................... BANDAGE TRIANGLE
• BANDAGE TUBULAR

Product Line

Machinery Required